Replies to post #246948 on Anavex Life Sciences Corp (AVXL)

[rayovacAAA]

YET HAMPEL LEFT THE AVXL TEAM AND WENT TO EISAI!!!!!!!!


Eisai installs new Alzheimer's clinical trial leadership team

Eisai unveiled the transfer of Irizarry to the new role alongside news of the appointment of Harald Hampel as VP, global medical affairs, Alzheimer's. The appointment puts Hampel in charge of coming up with Eisai’s global medical strategies in Alzheimer's and dementia. And he'll oversee phase 3b and 4 clinical trials of Alzheimer’s drugs, if one makes it that far.

GOOD LUCK AND GOD BLESS!!!!!!!!!!

[Investor2014]

mice to human conversion gobbiligook on a lazy sunday afternoon.

Not at all gobbledygook, if that is what you meant, but very useful for a biotech investor to understand when interpreting preclinical data and the way that might be used to frame outcome in humans.